BioWorld MedTech

April 27, 2010

Thoratec to sell ITC business to Danaher for $110 million

Heart device maker Thoratec (Pleasanton, California) said Monday it has agreed to sell its International Technidyne Corporation (ITC; Piscataway, New Jersey) division to Danaher (Washington) for $110 million in cash, plus about $26 million in earn-out payments. (Medical Device Daily) Read More

Fiber optics, nanotubes lead to neural constructs for bionics

Schultz upbeat about devices but venture capitalist worried

KCI in effort to launch mobile wound therapy system in 3Q10

Report from Europe: Implanet raises €8 million in additional funding round

Coming Wednesday in MDD Perspectives: Avoid unwarranted changes as part of 510(k) reform

Agreements/contracts: BG Medicine, Inverness to develop test for heart failure

Grants roundup: Funding given to centers for CPOE error research

Financings roundup: Vascular device maker Neovasc raises $1.4M in warrants exercise

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...